Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A Novel Pathway for a Mucosal TB Vaccine

Published: Friday, February 01, 2013
Last Updated: Friday, February 01, 2013
Bookmark and Share
Custom-designed adjuvants, developed at UB, boost immune responses against tuberculosis.

A new pathway for improving vaccines against tuberculosis has been discovered by microbiologists at the University at Buffalo in collaboration with researchers at other universities, according to a paper in the journal Mucosal Immunology, published by the Nature group.

Lead author on the study is Shabaana A. Khader, PhD, of the Department of Pediatrics, University of Pittsburgh; co-authors are Terry D. Connell, PhD, professor of microbiology and immunology in UB’s School of Medicine and Biomedical Sciences, and researchers from the University of Rochester and the University of Alabama.

The new pathway was identified in animal studies using LT-IIb, a novel, mucosal adjuvant, developed by Connell, who has shown that LT-IIb dramatically boosts the potency of vaccines that are administered to mucous membranes. Adjuvants enhance the body’s immune response against an antigen.

“This research demonstrates that the most effective vaccination against TB should target the IL-17 pathway,” says Connell, former director of UB’s Witebsky Center for Microbial Pathogenesis and Immunology.

“This observation is in stark contrast to the importance of the IFN-γ and T helper 1 pathways in combating TB infection in the body, which have been the traditional targets for TB vaccines,” he says.

“While those pathways are essential in overcoming infection, this published study indicates that they are likely to be less important in vaccination to elicit immune protection against TB,” he explains. The mechanisms that modulate IL-17-based protection are now being studied in laboratories around the world, he adds.

Connell’s lab is leading the study of LT-IIb and similar adjuvants that are derived from a unique group of bacterial proteins that belong to the type II family of bacterial heat-labile enterotoxins (HLT). These HLT are similar in structure and toxicity to cholera toxin but, interestingly, Connell notes, do not exhibit any detectible toxicities when employed as mucosal or systemic adjuvants.

“The adjuvants, which UB patented in 2008 have some unique characteristics,” says Connell.  “Depending on the type of adjuvant, one can either enhance the body’s ability to make antibodies or enhance the body’s cytotoxic response.  The great benefit of our type II HLT adjuvants is that these molecules can activate both pathways,” he says. “We can direct the type of immune response to the vaccine that is desired, whether an antibody response or a cellular response, simply by choosing one or the other type II adjuvant.”

Connell notes that there is a big push for development of mucosal vaccines against a number of pathogens in addition to TB that could be administered by some other route than injection. That’s because in the developing world, where the need for TB vaccination is greatest, it’s very difficult to store vaccines for long periods of time in conditions required for their stability, termed “the cold chain,” which is routinely required to maintain the efficacy and safety of most, if not all, injectable vaccines.

“Clearly, for use in developing areas of the world, the most optimal vaccine and adjuvant mixture would not require the ‘cold chain,’” says Connell. “Our mixtures of adjuvants and vaccines can be dried into a powder and stored on a shelf without refrigeration until needed.”

At that point, the adjuvant/vaccine powder would be added to water sterilized by boiling; the solution could then be sprayed into the nose from an atomizer.

The emergence of drug-resistant strains of Mycobacterium tuberculosis, and the more than 1.7 million deaths each year attributable to the disease, has provided a strong impetus for researchers to develop new methods to improve mucosal vaccines against tuberculosis.

Connell says the next step for this collaborative research is to identify the cellular and molecular mechanisms that underlie the capacity of LT-IIb to induce IL-17-associated immune response to antigens and pathogens.

“Once those mechanisms, have been identified, new mutant HLT can be engineered to further optimize the capacity of these adjuvants to enhance desired immune responses to candidate TB vaccines,” he says.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Brain Equation: Subtract Protein, Generate Myelin-Making Cells
A new way to generate oligodendrocytes has potential to enhance treatments for brain injury, MS, Alzheimer’s and more.
Thursday, August 20, 2015
Scientists Grow Human Serotonin Neurons in Petri Dish
The advance could facilitate the discovery of new antidepressants and drugs for illnesses involving serotonin.
Monday, August 10, 2015
Slinky Lookalike “Hyperlens” Helps Us See Tiny Objects
The photonics advancement could improve early cancer detection, nanoelectronics manufacturing and scientists’ ability to observe single molecules.
Tuesday, May 26, 2015
UB and Roswell Park receive $1.85M Grant to Launch Stem Cell Research Program
The program will bring together 18 faculty members to advance translation of stem cell breakthroughs into cell therapies.
Monday, May 18, 2015
Swiss Cheese Crystal, or High-Tech Sponge?
The remarkable properties of a new, porous material could lead to advances in microscopic sponging
Tuesday, January 28, 2014
New Imaging Technique Captures Protein Vibrations
Using a technique based on terahertz near-field microscopy scientists have for the first time observed in detail the vibrations of lysozyme.
Friday, January 17, 2014
Hybrid Nanoparticles for Multimodal Medical Imaging
The grant will fund research in which two or more medical imaging techniques are combined to provide complementary information.
Thursday, October 05, 2006
Chemical Sensors to Sniff out Diseases in Human Breath
Researchers are developing a Breathalyzer-type device to recognize biomarkers for certain diseases.
Tuesday, February 14, 2006
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Apricot Kernels Pose Risk of Cyanide Poisoning
Eating more than three small raw apricot kernels, or less than half of one large kernel, in a serving can exceed safe levels. Toddlers consuming even one small apricot kernel risk being over the safe level.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Genetic Markers Influence Addiction
Differences in vulnerability to cocaine addiction and relapse linked to both inherited traits and epigenetics, U-M researchers find.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
A lncRNA Regulates Repair of DNA Breaks in Breast Cancer Cells
Findings give "new insight" into biology of tough-to-treat breast cancer.
COPD Linked to Increased Bacterial Invasion
Persistent inflammation in COPD may result from a defect in the immune system that allows airway bacteria to invade deeper into the lung.
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!